ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 186 filers reported holding ARCUS BIOSCIENCES INC in Q3 2022. The put-call ratio across all filers is 1.07 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $301,874 | -28.6% | 19,821 | -11.5% | 0.00% | -50.0% |
| Q1 2024 | $422,893 | -12.0% | 22,399 | -10.9% | 0.00% | 0.0% |
| Q4 2023 | $480,423 | +8.7% | 25,153 | +2.2% | 0.00% | 0.0% |
| Q3 2023 | $441,965 | – | 24,622 | +2827.7% | 0.00% | – |
| Q2 2023 | $0 | -100.0% | 841 | -97.3% | 0.00% | -100.0% |
| Q4 2022 | $630 | -99.9% | 31,015 | -21.9% | 0.01% | -44.4% |
| Q3 2022 | $1,104,000 | -2.5% | 39,695 | +0.6% | 0.01% | 0.0% |
| Q2 2022 | $1,132,000 | – | 39,465 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,842,077 | $64,233,000 | 17.21% |
| Octagon Capital Advisors LP | 970,164 | $33,830,000 | 8.33% |
| Copernicus Capital Management, LLC | 17,000 | $593,000 | 7.18% |
| EcoR1 Capital, LLC | 5,122,359 | $178,617,000 | 6.21% |
| BVF INC/IL | 3,229,822 | $112,624,000 | 4.39% |
| PFM Health Sciences, LP | 3,431,010 | $119,639,000 | 3.52% |
| Alphabet Inc. | 4,100,475 | $142,984,000 | 3.39% |
| Boxer Capital, LLC | 2,084,883 | $72,700,000 | 2.54% |
| SECTORAL ASSET MANAGEMENT INC | 739,010 | $25,769,000 | 2.14% |
| Parkman Healthcare Partners LLC | 236,637 | $8,252,000 | 2.09% |